Table 2.
Results
| Mean ± SD | Dual en bloc KT n = 34 | Single KT n = 25 | P value |
| Patient survival | 32 (94.1%) | 20 (80%) | 0.12 |
| Graft survival | 31 (91.2%) | 17 (68%) | 0.04 |
| Follow-up (mo) | 52 ± 38 | 74 ± 41 | NS |
| Death-censored graft survival | 31/33 (93.9%) | 17/21 (81%) | 0.19 |
| DWFG | 1 (3%) | 4 (16%) | 0.15 |
| Months to DWFG | 15 | 54 ± 6.5 | NS |
| Delayed graft function | 4 (11.8%) | 5 (20%) | NS |
| # Days to SCr < 3.0 mg/dL | 4.7 ± 4.5 | 8.9 ± 7.2 | NS |
| Initial length of stay (d) | 5.4 ± 2.9 | 5.6 ± 3.4 | NS |
| Acute rejection in 1st year | 2 (5.9%) | 4 (16%) | NS |
| Surgical complications | 1 (2.9%) | 1 (4%) | NS |
| 12 mo SCr (mg/dL) | 1.17 ± 0.3 | 1.35 ± 0.3 | NS |
| 12 mo GFR (mL/min per 1.73 m2) | 72.5 ± 18.4 | 60.5 ± 18.1 | NS |
| 4 yr SCr (mg/dL) | 1.0 ± 0.4 | 1.17 ± 0.4 | NS |
| 4 yr GFR (mL/min per 1.73 m2) | 81 ± 21.9 | 64.4 ± 18.1 | NS |
KT: Kidney transplantation; SCr: Serum creatinine; DWFG: Death with a functioning graft; GFR: Glomerular filtration rate; NS: Not significant.